A synthetic dipeptide (Glu-Asp) bioregulator from the Khavinson peptide family, studied for urinary tract and prostate support. Research suggests it may help with bladder function and prostate microcirculation. Part of the tissue-specific bioregulatory compounds developed over 40+ years of research.

Is Vesilute FDA approved?

No, Vesilute is not FDA approved. Current status: Preclinical - Limited human studies, available as supplement in some regions

What are the side effects of Vesilute?

Reported side effects of Vesilute include: Generally well-tolerated, Limited safety data in Western literature, Individual intolerance possible, Unknown long-term effects.

What is the typical dosing for Vesilute?

Khavinson bioregulator dosing. Common doses observed in research: 10-20 mg daily (1-2 capsules), Standard: 10 mg per capsule. Duration: 30-day courses, repeat after 4-6 months. Administration: Oral capsules.

Anti-Aging

Vesilute

Also known as: ED Dipeptide, Glu-Asp, L-Glutamyl-L-Aspartic Acid

Preclinical

Popular For

Bladder health, urinary function, prostate support

Key Facts: Vesilute

Category: Anti-Aging
FDA Status: Not FDA Approved
Clinical Status: Preclinical - Limited human studies, available as supplement in some regions
Administration: Oral capsules
Typical Dose: 1-2 capsules (10-20 mg) daily
Frequency: 1-2x daily, before meals
Evidence Level: Preclinical
Duration: 30-day courses, repeat after 4-6 months

Also Known As

ED Dipeptide, Glu-Asp, L-Glutamyl-L-Aspartic Acid

Mechanism of Action

Vesilute is a dipeptide bioregulator that targets urogenital tissue. It is believed to normalize cellular function by reducing peptide deficiency and restoring protein synthesis inside cells. Research suggests it may enhance microcirculation within the prostate and support bladder function through epigenetic regulation of gene expression.

Research Summary

Part of Professor Khavinson's bioregulator research at the Saint Petersburg Institute of Bioregulation and Gerontology. Studies investigate potential role in supporting urinary tract and prostate health. Research suggests it may alleviate symptoms linked to bladder dysfunction and reduce prostate issues by improving local circulation. Limited published peer-reviewed data compared to other Khavinson peptides.

Clinical Status:Preclinical - Limited human studies, available as supplement in some regions

Trial Progress:Preclinical

Pre

III

FDA

Dosing Information

Preclinical·Limited published research, primarily anecdotal

Typical DosingⓘDoses commonly used by people in practice, based on community reports and anecdotal experience.

Community experience

Common Dose

1-2 capsules (10-20 mg) daily

Range

10-20 mg per day

Frequency

1-2x daily, before meals

Khavinson bioregulator for urogenital support. Often used in 30-day cycles. May be combined with Prostamax for prostate support in men. Limited Western research available.

Research DosingⓘDoses from published scientific studies and clinical trials. May include human or animal research.

Scientific studies

Khavinson bioregulator dosing

Doses from Studies

10-20 mg daily oral

Khavinson Bioregulator Protocol - Standard bioregulator dosing for urogenital support ↗

Duration

30-day courses, repeat after 4-6 months

Administration

Oral capsules

Timing & Administration

Best Time to Take

Morning, before meals

1-2 times daily

Food Recommendation

With or without food

Why This Timing?

Bioregulator peptides typically taken morning on empty stomach for optimal absorption.

Possible Side Effects

Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.

●Generally well-tolerated
●Limited safety data in Western literature
●Individual intolerance possible
●Unknown long-term effects

References

https://www.peptidesciences.com/vesilute-bioregulator-20mg

Related Peptides

Peptides commonly compared with Vesilute or used in similar applications.

Humanin

Preclinical

A mitochondria-derived peptide discovered for its neuroprotective effects against Alzheimer's-related toxicity. Being studied for aging and metabolic benefits.

Anti-Aging

FOXO4-DRI

Preclinical

A senolytic peptide designed to selectively eliminate senescent 'zombie' cells by disrupting the FOXO4-p53 interaction. Shows promise for restoring tissue function in aging, including kidney health restoration.

Anti-Aging

Glutathione

Clinical Trials

The body's master antioxidant - a tripeptide composed of glutamate, cysteine, and glycine. Found in every cell at concentrations similar to glucose (5mM). Essential for detoxification, immune function, and cellular protection against oxidative stress.

Anti-Aging

DSIP

Clinical Trials

A neuropeptide that promotes deep delta wave sleep. First isolated from rabbit brains in 1977. Used for sleep optimization and stress reduction.

Anti-Aging

NAD+ Precursors

Clinical Trials

While not peptides, NAD+ precursors are frequently discussed alongside peptides in longevity circles. They boost cellular NAD+ levels, supporting energy metabolism and sirtuin activity.

Anti-Aging

SS-31

FDA

A mitochondria-targeted peptide that improves cellular energy production. FDA approved for Barth syndrome (September 2025) as FORZINITY, the first approved mitochondria-targeted therapeutic.

Anti-Aging

How to Use Vesilute Vesilute Alternatives Compare with Similar Browse All Peptides

Looking for a trusted vendor?

Pro members get access to verified vendors with quality standards & exclusive discount codes.

View Verified Vendors

PRO

Want updates on Vesilute research?

Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.

Educational Information Only

This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.

Back to all peptides